GlassScriptPhysician profile
Nancy A Scangarello
NPI 1477598928
$3,032.12
in general payments reported to CMS, 2019-2025
9 companies · $460 in 2025
The $460 reported for 2025 was more than what 88% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,002 · 2022: $256 · 2023: $767 · 2024: $547 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,730 · Education: $43.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,729.65 |
| Education | $43.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $1,148.82 | 2021-2025 | Egrifta, Trogarzo, Egrifta Sv |
| Viiv Healthcare Company | $858.25 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $688.10 | 2021-2025 | Biktarvy, Sunlenca |
| Emd Serono, INC. | $151.89 | 2021-2025 | Serostim |
| Merck Sharp & Dohme LLC | $65.15 | 2022-2023 | Delstrigo, Pifeltro, Dificid |
| Abbvie INC. | $52.14 | 2022-2023 | |
| Janssen Biotech, INC. | $39.10 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.63 | 2025 | Uzedy |
| Madrigal Pharmaceuticals | $14.04 | 2024 | Resmetirom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Scangarello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.